Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsInitiationPrice Target
Guggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.
Guggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.